David P Schenkein's Net Worth
David P Schenkein's net worth is estimated to be at least $55,172,748.70 as of 11/09/2024. CoreStreet's estimation of David P Schenkein's net worth is based on their sale of stock and current holding of stock.
David P Schenkein is Director at Agios Pharm. They have executed at least 45 trades of stock as per SEC Form 4 filings. Their most recent trade was for 16,363 units of AGIO stock on 04/03/2023. Their biggest sale was on 10/04/2017 when they sold 80,000 units of Agios Pharm stock for $5,611,200.00. They typically trade 6 times per year.
Total value of insider buys:
- $249,984.00
Total value of insider sells:
- $54,922,764.70
Most recent insider trade:
- April 3, 2023
David P Schenkein's Insider Trading History
| Agios Pharm | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
April 3, 2023 | Director | 16,363 | $22.85 | Sell | $373,894.55 |
March 27, 2023 | Director | 20,000 | $22.15 | Sell | $443,000.00 |
March 13, 2023 | Director | 20,000 | $22.49 | Sell | $449,800.00 |
Feb. 13, 2023 | Director | 20,000 | $28.62 | Sell | $572,400.00 |
Jan. 30, 2023 | Director | 20,000 | $29.33 | Sell | $586,600.00 |
Jan. 17, 2023 | Director | 20,000 | $28.85 | Sell | $577,000.00 |
Nov. 13, 2019 | Director | 8,064 | $31.00 | Buy | $249,984.00 |
June 1, 2018 | CEO | 13,000 | $95.35 | Sell | $1,239,550.00 |
May 30, 2018 | CEO | 45,626 | $90.07 | Sell | $4,109,533.82 |
May 23, 2018 | CEO | 49,374 | $90.40 | Sell | $4,463,409.60 |
May 1, 2018 | CEO | 13,000 | $83.04 | Sell | $1,079,520.00 |
April 2, 2018 | CEO | 13,000 | $77.72 | Sell | $1,010,360.00 |
March 1, 2018 | CEO | 13,000 | $81.09 | Sell | $1,054,170.00 |
Feb. 1, 2018 | CEO | 13,000 | $78.75 | Sell | $1,023,750.00 |
Jan. 26, 2018 | CEO | 23,572 | $81.09 | Sell | $1,911,453.48 |
Jan. 24, 2018 | CEO | 46,408 | $80.01 | Sell | $3,713,104.08 |
Jan. 16, 2018 | CEO | 53,000 | $73.16 | Sell | $3,877,480.00 |
Dec. 1, 2017 | CEO | 6,000 | $61.55 | Sell | $369,300.00 |
Nov. 1, 2017 | CEO | 6,000 | $63.85 | Sell | $383,100.00 |
Oct. 4, 2017 | CEO | 80,000 | $70.14 | Sell | $5,611,200.00 |
Oct. 2, 2017 | CEO | 6,000 | $66.76 | Sell | $400,560.00 |
Sept. 18, 2017 | CEO | 35,000 | $67.12 | Sell | $2,349,200.00 |
Sept. 1, 2017 | CEO | 6,000 | $62.20 | Sell | $373,200.00 |
Aug. 2, 2017 | CEO | 27,000 | $59.95 | Sell | $1,618,650.00 |
July 3, 2017 | CEO | 3,000 | $51.18 | Sell | $153,540.00 |
June 7, 2017 | CEO | 3,000 | $50.02 | Sell | $150,060.00 |
May 1, 2017 | CEO | 3,000 | $50.06 | Sell | $150,180.00 |
April 3, 2017 | CEO | 3,000 | $58.62 | Sell | $175,860.00 |
Feb. 16, 2017 | CEO | 6,000 | $50.01 | Sell | $300,060.00 |
June 1, 2015 | CEO | 13,000 | $120.67 | Sell | $1,568,710.00 |
May 27, 2015 | CEO | 8,929 | $120.05 | Sell | $1,071,926.45 |
May 12, 2015 | CEO | 5,200 | $110.02 | Sell | $572,104.00 |
May 8, 2015 | CEO | 3,900 | $101.32 | Sell | $395,148.00 |
April 13, 2015 | CEO | 3,900 | $100.03 | Sell | $390,117.00 |
April 1, 2015 | CEO | 3,900 | $92.54 | Sell | $360,906.00 |
March 2, 2015 | CEO | 7,800 | $107.05 | Sell | $834,990.00 |
Feb. 13, 2015 | CEO | 1,471 | $120.22 | Sell | $176,843.62 |
Feb. 2, 2015 | CEO | 10,400 | $114.31 | Sell | $1,188,824.00 |
Jan. 2, 2015 | CEO | 13,000 | $110.08 | Sell | $1,431,040.00 |
Dec. 1, 2014 | CEO | 13,000 | $97.03 | Sell | $1,261,390.00 |
Sept. 26, 2014 | CEO | 60,000 | $62.68 | Sell | $3,760,800.00 |
Aug. 11, 2014 | CEO | 4,530 | $40.17 | Sell | $181,970.10 |
July 1, 2014 | CEO | 13,000 | $46.52 | Sell | $604,760.00 |
| Denali Therapeutics Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Nov. 12, 2020 | Director | 30,000 | $70.05 | Sell | $2,101,500.00 |
Nov. 4, 2020 | Director | 10,000 | $50.18 | Sell | $501,800.00 |